Markets › India › NSE › INDSWFTLAB

Ind-Swift Laboratories Ltd

NSE:INDSWFTLABHealthcare

₹351.90−2.05%At closeAt close · Mon 19 Oct · ≈ AED 13.58 · Market cap $328.08M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	42.1%	39.4%	36.5%	32.3%	48.7%	29.7%	—	—
Operating margin	12.4%	8.9%	15.0%	15.7%	−7.8%	2.3%	2.3%	+0.0 pts
Net margin	−0.4%	−0.2%	3.9%	32.9%	44.6%	6.5%	6.5%	+0.0 pts
EBITDA margin	22.2%	22.6%	19.5%	61.1%	50.8%	7.0%	—	—
Return on equity	−0.5%	−0.4%	7.0%	45.0%	21.4%	3.0%	3.0%	+0.0 pts
Return on assets	−0.2%	−0.1%	2.6%	28.8%	17.4%	2.5%	2.5%	+0.0 pts
Return on capital employed	7.4%	6.3%	12.5%	16.2%	−3.6%	1.0%	—	—
Debt / equity	1.7×	1.6×	1.3×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	55.3%	52.9%	47.3%	1.1%	2.8%	1.2%	—	—
Interest coverage	1.1×	1.0×	2.0×	3.9×	−15.0×	10.3×	—	—
Current ratio	3.0×	3.2×	3.1×	4.4×	3.9×	3.8×	3.8×	+0.0%
Quick ratio	1.8×	1.9×	2.0×	3.9×	3.4×	3.2×	—	—
Cash ratio	0.0×	0.1×	0.0×	2.3×	1.9×	1.7×	1.7×	+0.0%
Asset turnover	0.5×	0.6×	0.7×	0.9×	0.4×	0.4×	—	—
Inventory turnover	1.4×	1.5×	1.7×	8.0×	2.5×	3.0×	—	—
Receivables turnover	1.9×	2.1×	2.3×	7.6×	3.4×	3.2×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.